Investment area
Growth Investments
Planetary Health Investments
Region
Europe
Date of investment
April 2021
AMSilk is the world's first industrial supplier of smart biotech materials based on silk proteins for a variety of applications such as textile fibers, medical devices and consumer goods.
Contact
Anders Bendsen Spohr
Senior Partner, Head of Planetary Health Investments
Departments: Life Sciences Operating Committee, Planetary Health Investments
Anders joined Novo Holdings A/S in 2017.
Anders is Sr Partner and Head of the Planetary Health Investments team.
Prior to joining Novo Holdings, Anders was employed as VP in Xellia Pharmaceuticals heading up the Global Product Supply. Other previous employments include EVP, Global Product Supply at Leo Pharma A/S and VP Global Supply Chain at Novozymes A/S.
Anders holds a PhD in Biotechnology and a MSc in Chemical Engineering from Technical University of Denmark as well as a graduate diploma in Business Administration (International Business) from Copenhagen Business School.
Contact
Marcus Remmers
Partner
Department: Planetary Health Investments
Marcus joined Novo Holdings A/S in October 2022 as Partner in the Planetary Health Investments team taking part in managing and developing the growing portfolio of investments.
Marcus has more than 25 years of experience with several senior leadership roles across the globe having worked in the US, Germany, Mexico, Austria and the UK. Previously, he was Chief Technology Officer at Royal DSM and prior to that held various positions in the Animal Health Industry including leadership of Biologics and Pharma R&D, global M&A licensing and Country President. Marcus is passionate about innovation and sustainability and also serves as a member of the Global Expert Network of the World Economic Forum.
Marcus holds a doctorate in Polymer Chemistry (1997) from the Max Planck Institute for Polymer Research and a Diploma in Chemistry from the University of Freiburg, Germany.